Atul D. Jain

972 total citations · 1 hit paper
17 papers, 711 citations indexed

About

Atul D. Jain is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Atul D. Jain has authored 17 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Atul D. Jain's work include Genomics, phytochemicals, and oxidative stress (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Ion channel regulation and function (3 papers). Atul D. Jain is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Ion channel regulation and function (3 papers). Atul D. Jain collaborates with scholars based in United States, United Kingdom and China. Atul D. Jain's co-authors include Terry W. Moore, Gary E. Schiltz, Rama K. Mishra, Richard A. Glennon, Thomas E. Speltz, Barbara Lysy, Vinay Sagar, Huiying Han, Yara Rodríguez and Jonathan F. Anker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Atul D. Jain

17 papers receiving 708 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy

2019 302 citations Huiying Han, Atul D. Jain et al. Cancer Cell profile →

Peers

Countries citing papers authored by Atul D. Jain

Since Specialization

Citations

This map shows the geographic impact of Atul D. Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul D. Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul D. Jain more than expected).

Fields of papers citing papers by Atul D. Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul D. Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul D. Jain. The network helps show where Atul D. Jain may publish in the future.

Co-authorship network of co-authors of Atul D. Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Atul D. Jain. A scholar is included among the top collaborators of Atul D. Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul D. Jain. Atul D. Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Genesis and regulation of C-terminal cyclic imides from protein damage 2024 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Matthew P. Su, Atul D. Jain, (unknown), (unknown), (unknown), Christina M. Woo	8
2	Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models 2023 ·Journal of Clinical Investigation ·Xu Han, Yang Mei, Rama K. Mishra, Honghao Bi, Atul D. Jain, Gary E. Schiltz, Baobing Zhao, Madina Sukhanova, Pan Wang, Arabela A. Grigorescu, Patricia C Weber, John J. Piwinski, Miguel A. Prado, João A. Paulo, Len Stephens, Karen E. Anderson, Charles S. Abrams, Jing Yang, Peng Ji	11
3	Synthesis and Evaluation of Noncovalent Naphthalene-Based KEAP1-NRF2 Inhibitors 2020 ·ACS Medicinal Chemistry Letters ·(unknown), Atul D. Jain, (unknown), (unknown), (unknown), (unknown), (unknown), Kiira Ratia, Terry W. Moore	20
4	Targeting Pleckstrin-2 for the Treatment of Myeloproliferative Neoplasms 2020 ·Blood ·(unknown), (unknown), Gary E. Schiltz, Rama K. Mishra, Atul D. Jain, Peng Ji	1
5	Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy breakdown → 2019 ·Cancer Cell ·Huiying Han, Atul D. Jain, Mihai I. Truica, (unknown), Jonathan F. Anker, Barbara Lysy, Vinay Sagar, Yi Luan, Zachary R. Chalmers, Kenji Unno, Hanlin Mok, Rajita Vatapalli, Young A. Yoo, Yara Rodríguez, Irawati Kandela, J. Brandon Parker, Debabrata Chakravarti, Rama K. Mishra, Gary E. Schiltz, Sarki A. Abdulkadir	302
6	Abstract 1287: Targeting pleckstrin-2 for the JAK2-STAT and PI3K-Akt pathways in cancer therapy 2019 ·Cancer Research ·Xu Han, Yang Mei, Gary E. Schiltz, Rama K. Mishra, Atul D. Jain, Peng Ji	1
7	Abstract 1287: Targeting pleckstrin-2 for the JAK2-STAT and PI3K-Akt pathways in cancer therapy 2019 ·Xu Han, (unknown), Gary E. Schiltz, Rama K. Mishra, Atul D. Jain, Peng Ji	1
8	Replacement of a Naphthalene Scaffold in Kelch-like ECH-Associated Protein 1 (KEAP1)/Nuclear Factor (Erythroid-derived 2)-like 2 (NRF2) Inhibitors 2018 ·Journal of Medicinal Chemistry ·(unknown), Atul D. Jain, Haranatha R. Potteti, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aleksej Krunić, Sekhar P. Reddy, Terry W. Moore	42
9	des-Formylflustrabromine (dFBr): A Structure–Activity Study on Its Ability To Potentiate the Action of Acetylcholine at α4β2 Nicotinic Acetylcholine Receptors 2018 ·ACS Chemical Neuroscience ·Maƚgorzata Dukat, Atul D. Jain, Nadezhda German, (unknown), (unknown), (unknown), Marvin K. Schulte, Richard A. Glennon	7
10	Development of GLUT4-selective antagonists for multiple myeloma therapy 2017 ·European Journal of Medicinal Chemistry ·Changyong Wei, Richa Bajpai, Horrick Sharma, Monique R. Heitmeier, Atul D. Jain, Shannon M. Matulis, Ajay K. Nooka, Rama K. Mishra, Paul W. Hruz, Gary E. Schiltz, Mala Shanmugam	40
11	Time‐Gated Detection of Cystathionine γ‐Lyase Activity and Inhibition with a Selective, Luminogenic Hydrogen Sulfide Sensor 2016 ·Chemistry - A European Journal ·Yao Yao, (unknown), Liang Yin, Atul D. Jain, Kiira Ratia, Gregory R. J. Thatcher, Terry W. Moore, Tom G. Driver, Lawrence W. Miller	16
12	Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators 2015 ·European Journal of Medicinal Chemistry ·Atul D. Jain, Haranatha R. Potteti, (unknown), Laura J. Kingsley, (unknown), (unknown), Hyun Lee, Aleksej Krunić, Andrew D. Mesecar, Sekhar P. Reddy, Terry W. Moore	86
13	Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Atul D. Jain, Thomas E. Speltz, Terry W. Moore	68
14	Desformylflustrabromine (dFBr) and [3H]dFBr-Labeled Binding Sites in a Nicotinic Acetylcholine Receptor 2015 ·Molecular Pharmacology ·Ayman K. Hamouda, Zejun Wang, Deirdre S. Stewart, Atul D. Jain, Richard A. Glennon, Jonathan B. Cohen	17
15	Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters 2015 ·ACS Chemical Neuroscience ·Renata Kolanoś, Farhana Sakloth, Atul D. Jain, John S. Partilla, Michael H. Baumann, Richard A. Glennon	68
16	Deconstruction of the α4β2 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator Desformylflustrabromine 2011 ·Journal of Medicinal Chemistry ·Nadezhda German, Jin Sung Kim, Atul D. Jain, Maƚgorzata Dukat, Anshul A. Pandya, (unknown), Maegan M. Weltzin, Marvin K. Schulte, Richard A. Glennon	17
17	Role and differential expression of calpastatin mRNA and protein in cultured cardiomyocytes exposed to hypoxic stress 2004 ·Molecular and Cellular Biochemistry ·Huey Lin, (unknown), Atul D. Jain, (unknown), Techung Lee	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact